Speakers

Thomas Brenn

Department of Pathology, Western General Hospital, Edinburgh, UK

Dr. Thomas Brenn graduated magna cum laude from the Ruprecht-Karls University of Heidelberg (Heidelberg, Germany) where he received his MD and PhD degrees. After postdoctoral fellowships in the Departments of Genetics and Pathology at Stanford University (Stanford, CA, USA) and residency training in Anatomic Pathology at the Brigham and Women’s Hospital (Boston, MA, USA), he pursued subspecialty fellowships with Drs. Phillip McKee and Christopher Fletcher in Dermatopathology, Soft Tissue Tumor Pathology and Surgical Pathology. In 2003, Dr. Brenn joined the faculty of the Brigham and Women’s Hospital and Harvard Medical School and was a consultant in pathology at Dana Farber Cancer Institute.  In 2007, he was made Consultant Dermatopathologist and Head of Dermatopathology at NHS Lothian University Hospitals Trust and Honorary Senior Lecturer at the University of Edinburgh (Edinburgh, Scotland). Dr. Brenn is a Diplomate of the American Board of Pathology (Anatomic Pathology) and Dermatology (Dermatopathology). He is the current Chair of the Skin Working Group of the European Society of Patology (ESP), Chief Examiner for the RCPath Diploma in Dermatopathology and Associate Editor for Histopathology. He is also a member of the steering committee of the National Specialist EQA scheme in Dermatopathology and served on the executive committee of the British Society for Dermatopathology.  He has contributed to major textbooks in Dermatology and Dermtopathology and is a co-editor of the 4th edition of McKee’s Pathology of the Skin. His clinical and research interests are in the areas of cutaneous soft tissue tumors, skin adnexal tumors as well as melanocytic tumor pathology. 

Joseph Carlson

Department of Pathology, Karolinksa University Hospital, Stockholm, Sweden

Dr. Joseph Carlson was born in San Francisco, USA. He studied Physics at the Johns Hopkins University from 1990-94, earned his PhD in Biophysics and Computational Biology in the laboratory of Prof. Stephen G. Sligar at the University of Illinois – Urbana/Champaign, and then studied medicine in the Health Science and Technology program, attending both Harvard Medical School and the Massachusetts Institute of Technology.
After obtaining his MD he completed his internship and residency at the Brigham and Women’s Hospital, Harvard Medical School. In 2006 he continued his education with a fellowship in Women’s and Perinatal Pathology under the supervision of Prof. Christopher P. Crum. In 2007 he moved to Stockholm and joined the Department of Pathology at the Karolinksa University Hospital. He is currently a senior consultant (“överläkare”) with responsibility for gynecologic pathology. He is also a clinical scientist at the Karolinska Institutet, where he is a docent in the laboratory of Prof. Monica Nistér. His research is focused on endometrial cancer and uterine sarcomas.

Birgit Guldhammer Skov

Department of Pathology, Rigshospitalet, Copenhagen University Hospital, Denmark

Birgit Guldhammer Skov MD, DMSci,  is certified in Pathology and Cytology. She graduated from the Copenhagen University of Medicine in 1981. She has a broad education in medicine before entering the pathology in which she was certified in 1994. She defended her thesis in 1995 (Accuracy and reproducibility of immunohistochemistry in the diagnosis of pulmonary neoplasms). Since  1996 she has worked primary with pulmonary diseases.
Since 1996 Dr. Skov was Co-chair in different Depts. of Pathology, now at Copenhagen University Hospital, Rigshospitalet. Since 1991 she was an assistant professor at the University of Copenhagen. She is active in lung cancer research, in particularly in targeted therapy for NSCLC.

Anand C. Loya

Department of Pathology, Rigshospitalet, Copenhagen University Hospital, Denmark

Dr. Anand C. Loya is currently working as an Associate Professor of Pathology with University of Copenhagen, Denmark and as a Senior Consultant at Copenhagen University Hospital, Rigshospitalet with an experience of 18 years in Pathology.
Dr. Anand C. Loya qualified as M.B.B.S., M.D. (Pathology) from IGMC, Nagpur University, India. He completed his M.D. from Nagpur University, India in 2002 and underwent three years of Senior Residency at Nizam’s Institute of Medical Sciences (NIMS), Hyderabad, India. NIMS is a deemed University and a tertiary care institute of repute.
He was actively involved in presentations at state and national level when in India and also had been actively involved in teaching undergraduates and postgraduates.
He moved to Denmark in 2008 and has worked in the capacity of consultant and then in the capacity of senior consultant for the last 6 years with special interest in Genito-Urinary pathology and Soft Tissue pathology.
He is a member of European Society of Pathology (ESP) and an active member of European Uropathology Working Group.
He is an active member of Danish Uropathology Group.
He has several publications as author & co-author and is currently working on several projects in his field of his special interest.

Anais Malpica

Department of Pathology MD Anderson Cancer Center, Houston, TX, USA

Dr. Anais Malpica is a Professor of Pathology at The University of Texas M.D. Anderson Cancer Center. She received her M.D. degree from the Universidad Central de Venezuela in Caracas, Venezuela, and completed both Anatomic and Clinical Pathology residencies at Boston University and Baylor College of Medicine. This was followed by a fellowship in Surgical Pathology at The University of Texas M.D. Anderson Cancer Center. She was the former Director of the Gynecologic Pathology Section and Gynecologic Pathology Fellowship Program at MD Anderson. Dr. Malpica has authored and co-authored 220 scientific articles, 11 book chapters, and 2 books on gynecologic pathology. She is a member of the editorial board of the “International Journal of Gynecological Pathology” and “Archives of Pathology and Laboratory Medicine”. In addition, she was formally the Co-chair of the Educational Committee of the International Society of Gynecologic Pathology.

Cesar A. Moran

Department of Pathology MD Anderson Cancer Center, Houston, TX, USA

Dr. Cesar A. Moran is a professor of pathology and currently the Director of Thoracic Pathology and Deputy Chair in the department of pathology at M D Anderson Cancer Center.  Dr. Moran has authored more than 300 publications in peer review journals, written more than 45 chapters in diverse textbooks, and has authored 6 textbooks on thoracic pathology. Dr. Moran is the Editor-in-Chief of Annals of Diagnostic Pathology and has lectured in multiple countries around the world. In addition, a classification on thymomas and a staging system for thymomas and thymic carcinoma carries his name as one of the authors of such schemas.

Fredrik Petersson

National Cancer Institute and Department of Pathology, National University Hospital, Singapore

Dr. Fredrik Petersson is a Senior Consultant and Associate Professsor at the National Cancer Institute and Department of Pathology at the National University Hospital in Singapore. He graduated from Lund University, Sweden in 1992 with M.D. and received his M.D. licence from the Swedish Board of Health in 1994. Thereafter, he trained in Histopathology in Sweden and received his specialist qualification in Histopathology from the Swedish National Board of Health in 1999 and worked as a Consultant and Senior Consultant at the Department of Pathology, Karolinska University Hospital, Stockholm, Sweden. In 2004, he received his Ph.D in pathology from Linköping University. Dr Petersson has been a Clinical Observer and Researcher at the Department of Pathology, MD Anderson Cancer Center, University of Texas, Houston, USA and has been Visiting Professor at the Department of Pathology, Charles University Hospital, Pilsen, Czech Republic.

Eric Santoni-Rugiu

Department of Pathology, Rigshospitalet, Copenhagen University Hospital, Denmark

Dr. Eric Santoni-Rugiu (ESR) is board certified in Anatomic and Clinical Pathology and works as Consultant at the Department of Pathology of Rigshospitalet, Copenhagen University Hospital, where his main diagnostic area since 2005 has been thoracic pathology and molecular pathology. During these 12 years, he has been the responsible for pathological diagnostics of malignant pleural mesothelioma at Rigshospitalet, which is Scandinavian specialized referral center for the surgical and oncological treatment of this malignancy. ESR is a member of the International Mesothelioma Interest Group and the Advisory Board for Malignant Pleural Mesothelioma of the Danish National Board of Health.   

ESR graduated from the Faculty of Medicine at the University of Pisa, Italy, in 1988 with highest marks cum laude. After residency, he obtained a Doctorate of Research and PhD in Tumor Morphology and Experimental Oncology at the Department of Pathology in Pisa in 1994. From 1993 to 1997, he was a Postdoc at the National Cancer Institute (NCI) of the National Institutes of Health (NIH) in Bethesda, Maryland, USA, specializing in molecular pathology and carrying out research on human oncogenes.

At the end of 1997, ESR moved to Copenhagen, where he worked three years as Visiting Researcher at the Danish Cancer Society. During the period 1998-2000, he was also appointed Assistant Professor at the Department of Pathology of the University of Pisa and as advisor at the Molecular Pathology Unit of the European Institute of Oncology in Milan. From 2001 to 2007, he worked at the Pathology Departments of Bispebjerg, Herlev, and Rigshospitalet in Copenhagen, subsequently becoming Consultant Pathologist at Rigshospitalet and Associate Professor in Pathology at the Institute of Clinical Medicine of Copenhagen University. Since 1998, he has been teaching pathology and molecular pathology at courses for residents in Pathology and in Pneumology in Italy and Denmark. From 2008 to 2013, he was the leader of the Laboratory of Molecular Pathology of the Pathology Department at Rigshospitalet, and chairman of the Danish Molecular Pathology Group.

His current research activity is primarily focused on novel diagnostic and predictive biomarkers for malignant mesothelioma and lung cancer. ESR has published 86 peer-reviewed manuscripts and co-authored 26 book-chapters. He has lectured widely nationally and internationally on thoracic diseases and has staged over 40 oral presentations on pathology and molecular pathology at international meetings.

He is also member of the: Scientific Committee for the Danish Cancer Research Foundation; Scientific Board for the Danish Association for Cancer Research; American Association for Cancer Research; European Association for Cancer Research; European Molecular Pathology Group; European Society of Pathology; International Thymus & Mediastinum Interest Group; Nordic Thoracic Oncology Group.

Kanishka Sircar

Department of Pathology MD Anderson Cancer Center, Houston, TX, USA

Dr. Kanishka Sircar is an Associate Professor in Pathology and Translational Molecular Pathology at the University of Texas MD Anderson Cancer Center (Houston, TX).  He obtained his M.D. from McGill University (Montreal, QC), completed internship at the University of Calgary (Calgary, AB), residency training in Anatomical Pathology at McMaster University (Hamilton, ON) and subspecialty fellowships in Oncologic and Genitourinary Pathology at Memorial Sloan Kettering Cancer Center (New York, NY).  He is board certified in Anatomic Pathology in both Canada and the USA.  He previously served as Assistant Professor of Pathology at McGill University with a cross appointment in Urology.  Dr. Sircar is an experienced diagnostician and educator in Genitourinary Pathology who has served as an examiner for the Royal College of Physicians and Surgeons of Canada.  Dr. Sircar lectures nationally and internationally on a range of Genitourinary Pathology topics. He research interests include examining the lethal phenotype of prostate cancer as well as metastatic and sarcomatoid renal carcinoma using functional genomics approaches.

Carlos A. Torres-Cabala

Department of Pathology MD Anderson Cancer Center, Houston, TX, USA

Dr. Carlos A. Torres-Cabala is an Associate Professor at Departments of Pathology and Dermatology at The University of Texas MD Anderson Cancer Center, Houston, TX. He is also the Section Chief at the Dermatopathology Section, the Department of Pathology and the Division of Pathology/Lab Medicine at The University of Texas MD Anderson Cancer Center, Houston, TX

Dr. Torres-Cabala is a member of the Executive Committee, International Society of Dermatopathology and a former member of the International Partnering Committee and the American Society of Dermatopathology.

He is the author of over 70 peer-reviewed articles, 10 book chapters, and Editor of a book called Genetics of Melanoma (2016)

He also lectures in multiple US and international meetings and courses.